High CD47 expression has been demonstrated to correlate with a poor outcome in AML [16], chronic myelogenous leukemia [31], NHL [32] and some solid tumors (e.g., breast cancer, renal cell carcinoma, non-small cell lung cancer, thyroid cancer [33], etc.). The gene discussed is CD47; the disease is non-Hodgkin lymphoma.